Last Added


News Archive

Advertisement

FDA Recalls Mislabeled ReliOn Insulin Syringes

Friday, November 7, 2008
Share this
If you are a diabetic who uses insulin, please be aware that there has been a nationwide recall of ReliOn Insulin syringes.  The syringes are mislabeled and people may draw up more insulin than needed which could lower blood sugar.

From FDA Reports:
The U.S. Food and Drug Administration is notifying health care professionals and patients that Tyco Healthcare Group LP (Covidien) is recalling one lot of ReliOn sterile, single-use, disposable, hypodermic syringes with permanently affixed hypodermic needles due to possible mislabeling.  The use of these syringes may lead to patients receiving an overdose of as much as 2.5 times the intended dose, which may lead to hypoglycemia, serious health consequences, and even death.  According to Reuters, the syringes were sold in Wal-Mart and Sam's Club from August 1st until October 8th, the FDA said.  The affected lot number is 813900.

Covidien voluntarily recalled the syringes on Oct. 9, asking that any units of the affected product be removed from inventory and placed in quarantine, the agency said.

Wal-Mart posted the recall announcement in Wal-Mart stores and Sam's Clubs, as well as on its website and sent letters to more than 16,500 customers notifying them of the recall.

If you think that you have ReliOn syringes, contact Covidien at 866-780-5436 or go to the website
www.relion.com/recall.

Post a comment below to share with the community.


By The OurHealth Writing Team 

Post your Comment:


You have 1000 characters left.
Comments containing illegal content or in violation of our Terms of Use are strictly prohibited


Designed and Developed by Dassnagar